• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in

Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death

by Ellie Lampton | Aug 9, 2023

With new medication dispense data – including prescription fill data from specialty pharmacies – Truveta Data offers even more complete, timely, and clean data to study patient care and outcomes. BELLEVUE, Wash. – August 8, 2023 – Today Truveta announced the addition...
Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data

Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data

by Lish Schilter | May 17, 2023

BELLEVUE, Wash. – May 17, 2023 – Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion of its community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously...

JAMA Network Open publishes Truveta and Harvard University collaboration

by Lish Schilter | May 11, 2023

New research published in JAMA Network Open shows changes in minoxidil prescribing following media attention about oral use for hair loss. BELLEVUE, Wash. – May 11, 2023 – Today Truveta announced a new research letter published in JAMA Network Open using de-identified...

Truveta Language Model unlocks EHR data for the most complete and accurate medical research

by Ellie Lampton | Apr 12, 2023

Truveta’s clinical expert-led AI delivers the cleanest healthcare data, including structured concepts from clinician notes BELLEVUE, Wash. – April 12, 2023 – Today Truveta introduces the Truveta Language Model (TLM), a large-language, multi-modal AI model for...

Truveta and Alpine Immune Sciences announce strategic partnership to access Truveta’s community to accelerate recruitment to povetacicept clinical trials

by Ellie Lampton | Mar 22, 2023

Truveta’s 28 health system members provide over 16% of patient care in the United States. BELLEVUE and SEATTLE, Wash. – March 21, 2023 – Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial...
« Older Entries
Next Entries »

Share this


Recent posts

  • Truveta experts: Gestational diabetes screening in real-world practice
  • Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data
  • Johns Hopkins builds research community to explore new frontiers in health using Truveta Data

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.